Jupiter Neurosciences Inc
XNAS:JUNS
| Market Cap (Intraday) | 36.67M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 19 |
| 10-Day MA | $1.21 |
| 50-Day MA | $1.43 |
| 200-Day MA | $1.14 |
Jupiter Neurosciences Inc Stock, XNAS:JUNS
1001 North US Highway 1, Suite 504, Jupiter, Florida 33477
United States of America
Phone: +1.561.406.6154
Number of Employees:
Description
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Ros�©n, Alexander Ros�©n, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.